PRESS RELEASE
31 March 2021

Life Sciences Executive Exchange Series - Webinar Recap

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
In this series, designed for experienced pharma professionals and executives, Buchanan professionals will tackle critical issues to help you navigate the Pharma Product Lifecycle.
United States

In this series, designed for experienced pharma professionals and executives, Buchanan professionals will tackle critical issues to help you navigate the Pharma Product Lifecycle. In each 30-minute session, we will dive into a specific phase of the lifecycle, provide attendees with the latest pharma updates and cover trends happening within the FDA and the industry in general.

If you missed the conversation, you can access the recording below.

Session One: Navigating the FDA: Bringing New Therapies to Market

PRESS RELEASE
31 March 2021

Life Sciences Executive Exchange Series - Webinar Recap

United States

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More